Nanocan Therapeutics

References

Nanocan’s inaugural innovation derives from its worldwide exclusive license for Immunogenic Smart Radiotherapy Biomaterial (iSRB) technology. Read about the licensing of its iSRB technology here.
Publications on the iSRB technology are listed below:

Potential for Enhancing External Beam Radiotherapy for Lung Cancer Using High-Z Nanoparticles Administered Via Inhalation

Physics in Medicine and Biology
Published August 26, 2015

Smart Radiotherapy Biomaterials, A Preclinical Study

International Journal of Radiation Oncology, Biology, Physics
Published November 1, 2016

Enhancing Radiotherapy for Lung Cancer Using Immunoadjuvants Delivered In-Situ from New Design Radiotherapy Biomaterials

Physics in Medicine and Biology
Published December 2, 2016

Modeling Gold Nanoparticle-Eluting Spacer Degradation During Brachytherapy Application with In-Situ Dose Painting

British Journal of Radiology
Published June 6, 2017

Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids

Frontiers in Oncology
Published September 19, 2017

Using Immunotherapy to Boost Abscopal Effect

Nature Reviews Cancer
Published February 16, 2018

Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants

Frontiers in Oncology
Published March 12, 2018

Enhancing the Therapeutic Efficacy of Cancer Treatment with Cannabinoids

Frontiers in Oncology
Published April 24, 2018